Skip to main content
OpenTrials

Clinical trial condition

Monomorphic Post-Transplant Lymphoproliferative Disorder

Explore clinical trials studying Monomorphic Post-Transplant Lymphoproliferative Disorder. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Monomorphic Post-Transplant Lymphoproliferative Disorder trial results

Completed

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

NCT02900976

Conditions
EBV-Related Post-Transplant Lymphoproliferative Disorder, Monomorphic Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder, +4 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 38 locations
View Trial Details

Related conditions